FDA Investigator Dolores E Price

Dolores E Price has conducted inspections on 277 sites in 1 countries as of 19 Sep 2011. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

277

Last Inspection Date:

19 Sep 2011

Investigator Role:

FDA Investigator

Redica ID:

100002006

Countries of Inspections:

United States of America

FDA Investigators that have inspected at least one site in common with Dolores E Price:

Alan R Condon, Alexander M Kay, Alicia Aborg Borm, Alicia M Weitzel, Anita Narula, PhD, Arie C Menachem, Ashar P Parikh, Astrida B Mattson, Ava M Bowman, Avery J Dennis, Barbara D Wright, Barbara Janine Breithaupt, Barbara T Carmichael, Bradley Dworak, PhD, Bradley E Tufto, Brenda L Reihing, Brentley S Collins, Bryan Baker, Bryce E Mansfield, Burnell M Henry, Carl A Anderson, Caryn M Mcnab, Catherine J Laufmann, Ce'nedra M Martin, Christian D Lynch (CDL), Christina V Santos, Christine A Harman, PhD, Christopher S Genther, Cody D Rickman, Connie P Rezendes, Cynthia J Lee, MS, Dam S Barkans, Dan G Eisenbrey, Dana M Klimavicz, Dawn E Barkans, Deborah A Nebenzahl, Deborah Kleinfeld, Dennis G Kawabata, Dennis R Hudson, Devon M Shoop, Dianna D Wardlow Dotter, Dirk L Lincoln, Don A Brunssen, Don H Bark, PhD, Donald B Mckechnie, Donald W Jehn, Dr. Guang Gao, PhD, Edward A Brunt, Edward D Harris, Edwin Melendez, Eileen A Liu, Elizabeth D Connell, Elizabeth E Hart (ASCP), MT, Elmina E Akwo, Emily B Camire, Eric T Huebler, Francis A Guidry, Garrad R Poole, Gene D Arcy, Gerard Pde Leon, Gina C Collins, Gloria A Milster, Gloria J Baca, MS, Gordon T Wales, Hanna L Potter, Heika R Bounds, Heika R Tait, Hugh A Grimoldby, Jack L Christy, Jacqueline Mdiaz Albertini, James C Henry, James D Hildreth, Jane M Kreis, Jason T Lovelady, Jeffrey D Varelman, Jennifer L Bridgewater, Jessica B Clark, Jessica L Walters Moell, Jessica Walters Moell, Joey V Quitania, John A Iwen, John E Emmert, John W Banks, Julian C Hanson, Kaarin M Slotte, Karen J Bak, Kari M Johansen, Kathryn A Krentz, Kellie L Westerbuhr, Kelly D Moore, Kenneth O Gee, PhD, Kip J Hanks, Kristin M Abaonza, Laura Kathryn, Laurel A Beer, Lauren E Swantko, Laverne Puckett, LCDR Debra Emerson, LCDR Ismael Olvera, IV, Lee Terry Moore, Lesley A Swanson, Leya A Grosch, Linda S Leja, Lisa K Capron, Lisa M Althar, Lori J Silverstein, LTJG Bradley E Benasutti, Lynda L Perry, PhD, Marc A Jackson, Jr, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Mariza M Jafary, Mark E Moen, Mark W Babbitt, Marlene L Davis, Maxine H Wong, Michael F Schuette, Mihaly S Ligmond, Mikel T Wright, Nancy A Saxenian Emmons, Omotunde O Osunsanmi, Othello G Capangpangan, Ounchith J Phabmixay, Paul M Chefor, Paul M Kawamoto, Paula A Trost, Peter Kessler, PhD, Philip E Ake, Prabhu P Raju, Randy L Self, Rebecca Rodriguez, Rebecca T Davis, Richard Heath Coats, Richard J Bashay, Richard L Bartlett, Richard T Riggie, Robert D Tollefsen, Rocco C Black, Roger D Gawne, Roger J Adams, S Lori Brown, PhD MPH, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Scott A Nabe, Scott Reynolds, Scott W Fox, Sharon I Gundersen, Shelley H Beausoleil, Stephen D Weagant, Stephen R Souza, Stuart W Russell, Sunitha K Rajaram, PhD, Sunny R Muir, Susan F Laska, MS, Terri L Dodds, Thomas J Arista, Tiana M Mckinley, Tina S Roecklein, Tracy K Li, Travis S Bradley, Uttaniti Limchumroon (Tom), Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Victoria V Bot, William D Bassett, Jr, Xiaojun Yan, Xiomara Copeland, Young M Yoon

Dolores E Price's Documents

Show entries

Publish Date	Document Type	Title
June, 2009	FDA 483	Takeda Pharmaceutical Company Limited - Form 483, 2009-06-11
April, 2004	FDA 483	Our Lady of the Lake Hospital, Inc. - Form 483, 2004-04-08
April, 2004	EIR	Our Lady of the Lake Hospital, Inc. - EIR, 2004-04-08
April, 2004	FDA 483 Response	Our Lady of the Lake Hospital, Inc. - Form 483R, 2004-04-21
September, 2003	EIR	Bloodworks - EIR, 2003-09-12
September, 2003	FDA 483	Bloodworks - Form 483, 2003-09-12
September, 2003	FDA 483 Response	Bloodworks - Form 483R, 2003-09-30
August, 2003	FDA 483 Response	Bloodworks Northwest - Form 483R, 2003-08-21
August, 2003	FDA 483	Bloodworks Northwest - Form 483, 2003-08-01
August, 2003	EIR	Bloodworks Northwest - EIR, 2003-08-01

Showing 1 to 10 of 27 entries

Previous1 2 3Next

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more